As European markets experience a positive upswing, with the pan-European STOXX Europe 600 Index rising by 3.44% amid easing tariff concerns, investors are increasingly looking towards dividend stocks as a potential source of steady income. In this environment, selecting dividend stocks that offer robust yields and demonstrate resilience in economic fluctuations can be an effective strategy for those seeking to enhance their portfolios while navigating the current market dynamics. Top 10 Dividend Stocks In Europe Name Dividend Yield Dividend Rating Julius Bär Gruppe (SWX:BAER) 4.73% ★★★★★★ Zurich Insurance Group (SWX:ZURN) 4.37% ★★★★★★ Bredband2 i Skandinavien (OM:BRE2) 4.48% ★★★★★★ HEXPOL (OM:HPOL B) 4.89% ★★★★★★ Deutsche Post (XTRA:DHL) 4.85% ★★★★★★ S.N. Nuclearelectrica (BVB:SNN) 9.29% ★★★★★★ Cembra Money Bank (SWX:CMBN) 4.25% ★★★★★★ Rubis (ENXTPA:RUI) 7.06% ★★★★★★ Banque Cantonale Vaudoise (SWX:BCVN) 4.36% ★★★★★★ CaixaBank (BME:CABK) 8.33% ★★★★★☆ Click here to see the full list of 237 stocks from our Top European Dividend Stocks screener. Let's take a closer look at a couple of our picks from the screened companies. Tryg Simply Wall St Dividend Rating: ★★★★☆☆ Overview: Tryg A/S, with a market cap of DKK96.71 billion, offers insurance products and services to private, corporate, and small to medium-sized businesses across Denmark, Sweden, the United Kingdom, and Norway. Operations: Tryg A/S generates revenue primarily from its Private (Including Sweden) segment with DKK26.35 billion and its Commercial segment with DKK9.58 billion. Dividend Yield: 5.1% Tryg A/S recently announced a dividend of DKK 2.05 per share for the first quarter, reflecting its position as a top-tier dividend payer in Denmark with a yield of 5.09%. Despite this, the dividend is not well covered by earnings due to a high payout ratio of 95.4%, though it is supported by cash flows with a cash payout ratio of 65.1%. Earnings grew significantly by DKK 342 million year-on-year, but dividends have been historically volatile and unreliable over the past decade. Click to explore a detailed breakdown of our findings in Tryg's dividend report. In light of our recent valuation report, it seems possible that Tryg is trading behind its estimated value.CPSE:TRYG Dividend History as at May 2025 SpareBank 1 Nord-Norge Simply Wall St Dividend Rating: ★★★★★☆ Overview: SpareBank 1 Nord-Norge offers banking services in Northern Norway and has a market cap of NOK14.45 billion. Operations: SpareBank 1 Nord-Norge generates revenue from several segments, including Retail Market (NOK2.51 billion), Corporate Banking (Excluding SMB) (NOK1.71 billion), Eiendoms-Megler 1 Nord-Norge (NOK227 million), Sparebank 1 Finans Nord-Norge (NOK344 million), and Sparebank 1 Regnskaps-Huset Nord-Norge (NOK334 million). Story Continues Dividend Yield: 6.1% SpareBank 1 Nord-Norge recently proposed a cash dividend of NOK 8.75 per share, supported by strong earnings growth with net income reaching NOK 3.63 billion for 2024. The bank's dividends have been reliable and steadily increasing over the past decade, with a sustainable payout ratio currently at 53.7%. However, its dividend yield of 6.08% is lower than Norway's top-tier payers, and it faces challenges with a high level of bad loans at 2.6%. Click here and access our complete dividend analysis report to understand the dynamics of SpareBank 1 Nord-Norge. The analysis detailed in our SpareBank 1 Nord-Norge valuation report hints at an deflated share price compared to its estimated value.OB:NONG Dividend History as at May 2025 BioGaia Simply Wall St Dividend Rating: ★★★★☆☆ Overview: BioGaia AB (publ) is a healthcare company that offers probiotic products globally, with a market capitalization of approximately SEK10.66 billion. Operations: BioGaia AB (publ) generates revenue primarily from its Pediatrics segment, which accounts for SEK1.09 billion, and the Adult Health segment, contributing SEK321.29 million. Dividend Yield: 6.5% BioGaia's dividend yield ranks in the top 25% of Swedish payers, yet its high cash payout ratio suggests dividends aren't well covered by free cash flows. Despite a proposed SEK 1.95 per share dividend increase and an extra SEK 4.95 per share, historical volatility raises sustainability concerns. Recent earnings growth supports coverage with a reasonable payout ratio of 56.1%. A recent M&A transaction involves significant stake acquisitions, potentially impacting future shareholder dynamics and dividend policies. Unlock comprehensive insights into our analysis of BioGaia stock in this dividend report. Our valuation report here indicates BioGaia may be overvalued.OM:BIOG B Dividend History as at May 2025 Turning Ideas Into Actions Unlock more gems! Our Top European Dividend Stocks screener has unearthed 234 more companies for you to explore.Click here to unveil our expertly curated list of 237 Top European Dividend Stocks. Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive. Simply Wall St is a revolutionary app designed for long-term stock investors, it's free and covers every market in the world. Seeking Other Investments? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include CPSE:TRYG OB:NONG and OM:BIOG B. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected] View Comments
3 European Dividend Stocks Yielding Up To 6.5%
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...